Gloshell
Ingredients

Ingredient Dictionary

DIETHYLHEXYL BUTAMIDO TRIAZONE

Korean limit
10%
Molecular structure

How much products actually contain

No product states its amount yet.

Of the products containing it, 72 list it before the 1% line and 0 after it (usually 1% or less).

Products using this ingredient

12 of 72 confirmed · likeliest to carry enough first · See all 72

Definition

US FDA substance register · UNII 2UTZ0QC864 · registered name ISCOTRIZINOL · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Diethylhexyl Butamido Triazone is the organic compound that conforms to the formula:

Cosmetic roles

Absorbs UV (including to protect the product)UV ABSORBERFilters UV to protect skin (sunscreen active)UV FILTERProtects colour and scent from lightLIGHT STABILIZER

Safety & regulatory references

Allowed UV filter
United Kingdom

Source: ASEAN Cosmetic Directive · EU Cosmetics Regulation · Taiwan FDA cosmetic ingredients · UK cosmetics regulations (OPSS)

Argentina · Brazil

  • Maximum concentration permitted at final product : 10%

ASEAN

  • Maximum authorised concentration in the finished cosmetic product : 10%

Taiwan · China · South Korea

  • Maximum concentration : 10%

European Union

  • Maximum concentration in ready for use preparation : 10%

Source: MFDS (Korea) cosmetic regulatory information

EU Cosmetics Regulation, Annex VI (allowed UV filters), entry 17 · maximum concentration 10%

Source: EU allowed UV filters (Annex VI)

Restriction VI/17 · Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Official labels & definitions

JCIA labelling name ジエチルヘキシルブタミドトリアゾン: 本品は、次の化学式で表される有機化合物である。

Source: JCIA labelling names (Japan)

Names & identifiers

DIETHYLHEXYL BUTAMIDO TRIAZONEINCI디에칠헥실부타미도트리아존Korean label name (MFDS standard)ジエチルヘキシルブタミドトリアゾンJapanese labelling name
CAS No.chemical registry number
154702-15-5
DTXSIDUS EPA chemical ID
DTXSID40870027
DTXCIDUS EPA compound ID
DTXCID50817887
IUPAC
Bis(2-ethylhexyl) 4,4'-[{6-[4-(tert-butylcarbamoyl)anilino]-1,3,5-triazine-2,4-diyl}bis(azanediyl)]dibenzoate
Molecular formula
C44H59N7O5
Molecular weight
766 g/mol

Irritation and sensitisation studies

6 skin studies and 3 eye studies are on record.

Classed as low6

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 9 studies
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: OECD Guidelines 406 EEC B.6 method, Section 4.1.7, Maximization test according to Magnusson and Kligman.
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: EEC Guidelines B.4, Section 4.1.5 OECD 404 according to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) according to EU Method B.6 (Skin Sensitisation)
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: EEC Guidelines B.5(Section 4.1.6) and OECD 405 according to

Source: US EPA CompTox dashboard

Related literature

Linked databases 20